https://news.pts.org.tw/article/510515
中國醫藥大學科研團隊研究,發現單寧酸會雙重抑制新型冠狀病毒(SARS-CoV-2)的主要蛋白酶和跨膜絲胺酸蛋白酶2,能抑制病毒活性,對COVID-19治療有高度前瞻性。
The content above by Cofacts message reporting chatbot and crowd-sourced fact-checking community is licensed under Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA 4.0), the community name and the provenance link for each item shall be fully cited for further reproduction or redistribution.